^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IP-001

    i
    Other names: IP-001, N-dihydro-galacto-chitosan
    Associations

    News

    Trials
    Company:
    Immunophotonics
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    5ms
    INJECTABL-1: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (clinicaltrials.gov)
    P1/2, N=44, Recruiting, Immunophotonics, Inc. | Phase classification: P1b/2a --> P1/2
    Phase classification
    |
    IP-001
    1year
    SAKK 66/17: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. (clinicaltrials.gov)
    P1/2, N=39, Recruiting, Swiss Group for Clinical Cancer Research | Trial completion date: Dec 2023 --> Dec 2025 | Trial primary completion date: Jun 2023 --> Jun 2025
    Trial completion date • Trial primary completion date • Metastases
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF mutation
    |
    IP-001
    2years
    Thermal Ablation Enhances Immunotherapeutic Effect of IP-001 on Orthotopic Liver Cancer in a Rat Model (SSO 2022)
    Introduction: : Immunosuppression within the tumor microenvironment of hepatocellular carcinoma (HCC) has made immune checkpoints attractive targets for therapy, however they have failed to improve overall survival (OS) as first-line monotherapy compared to sorafenib. A combination of IP-001 and MWA in an HCC Murine model led to significant increase in macrophages (CD11b + cells) dendritic cells (CD11b + CD 103 + cells), NK cells (CD 161 + cells), significant upregulation of interferon gamma, and improvement in T helper cells. Learning Objectives: Understand the combination effects of thermal ablation and N‐dihydrogalactochitosan injection Understand the immunomodulatory effects of MWA alone and in combination with N‐dihydrogalactochitosan injection Understand the HCC animal effects and immune profile that can be seen after ablation
    Preclinical
    |
    CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • ITGAM (Integrin, alpha M) • ITGAE (Integrin Subunit Alpha E) • KLRB1 (Killer Cell Lectin Like Receptor B1)
    |
    sorafenib • IP-001
    4years
    SAKK 66/17: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. (clinicaltrials.gov)
    P1/2, N=39, Not yet recruiting, Swiss Group for Clinical Cancer Research | Initiation date: Mar 2020 --> Jun 2020
    Clinical • Trial initiation date
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF mutation
    |
    IP-001
    over4years
    SAKK 66/17: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. (clinicaltrials.gov)
    P1/2, N=39, Not yet recruiting, Swiss Group for Clinical Cancer Research | Initiation date: Dec 2019 --> Mar 2020
    Clinical • Trial initiation date
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF mutation
    |
    IP-001